Detalhe da pesquisa
1.
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
Hepatology
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436992
2.
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase.
J Viral Hepat
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717914
3.
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.
J Hepatol
; 78(3): 534-542, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572349
4.
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study.
J Hepatol
; 66(1): 11-18, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27545497
5.
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
J Hepatol
; 64(4): 773-80, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626497
6.
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Cancer
; 121(20): 3631-8, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26177866
7.
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).
Liver Int
; 35(2): 422-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25277773
8.
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load.
Hepatology
; 58(2): 505-13, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23364953
9.
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients.
J Clin Transl Hepatol
; 12(5): 469-480, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779514
10.
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
Aliment Pharmacol Ther
; 59(2): 217-229, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905449
11.
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B.
Viruses
; 15(4)2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37112976
12.
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
JHEP Rep
; 5(10): 100847, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771546
13.
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data.
Aliment Pharmacol Ther
; 55(8): 921-943, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178711
14.
Associations between serum lipids and hepatitis C antiviral treatment efficacy.
Hepatology
; 52(3): 854-63, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20690192
15.
Reply: To PMID 23813604.
Hepatology
; 59(6): 2427, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24151059
16.
Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.
Antimicrob Agents Chemother
; 53(2): 615-21, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18852273
17.
Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.
Intervirology
; 52(1): 49-56, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19401628
18.
Sexual and alcohol risk behaviours of immigrant Latino men in the South-eastern USA.
Cult Health Sex
; 11(1): 17-34, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19234948
19.
Characteristics of a sample of men who have sex with men, recruited from gay bars and Internet chat rooms, who report methamphetamine use.
AIDS Patient Care STDS
; 21(8): 575-83, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17711382
20.
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
Hepatol Int
; 9(2): 243-50, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25788199